Skip to main content
padlock icon - secure page this page is secure

Outcome measures of antidepressive therapy

Buy Article:

$59.00 + tax (Refund Policy)

A variety of outcome measures assessing antidepressive therapy are available. However, in randomized clinical trials, the Hamilton Rating Scale for Depression (HAM‐D) is often the primary outcome measure. Results from factor analysis and Rasch item analysis indicate that the HAM‐D is heterogeneous and that the sum of items scores may not be an adequate measure of the severity of depression. A Melancholia Scale of 11 items has been suggested as a more valid measure of the core symptoms of affective syndrome. Other global outcome measures, focusing on health‐related quality of life issues and on social functioning as well as macro‐economic analyses are also used in depression. Applying stringent and well‐documented outcome measures in randomized clinical trials of antidepressants may give the clinician a better indication of the most appropriate drug for treatment of the individual patient.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Hamilton Rating Scale for Depression; depression; outcome measures; quality of life

Document Type: Original Article

Publication date: January 1, 2000

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more